0001758725-18-000002.txt : 20181113 0001758725-18-000002.hdr.sgml : 20181113 20181113141343 ACCESSION NUMBER: 0001758725-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181113 DATE AS OF CHANGE: 20181113 EFFECTIVENESS DATE: 20181113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nia Therapeutics, Inc. CENTRAL INDEX KEY: 0001758725 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-325631 FILM NUMBER: 181177150 BUSINESS ADDRESS: STREET 1: 1900 MARKET ST., 8TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-560-7402 MAIL ADDRESS: STREET 1: 1900 MARKET ST., 8TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 D 1 primary_doc.xml X0708 D LIVE 0001758725 Nia Therapeutics, Inc. 1900 MARKET ST., 8TH FLOOR PHILADELPHIA PA PENNSYLVANIA 19103 267-560-7402 DELAWARE Nia Therapeutics, LLC None Corporation true 2016 Daniel Rizzuto 1900 Market St., 8th Floor San Francisco CA CALIFORNIA 94103 Executive Officer Director Michael Kahana 1900 Market St., 8th Floor San Francisco CA CALIFORNIA 94103 Executive Officer Director Other Health Care Decline to Disclose 06b false 2018-10-31 false true true true false 0 2000000 850000 1150000 false 3 0 0 0 false Nia Therapeutics, Inc. /s/ Daniel Rizzuto Daniel Rizzuto Chief Executive Officer 2018-11-13